EDIT earnings: a positive outcome, +6.2%

On February 22, 2023, Editas Medicine, Inc. reached its earnings. The result was a positive outcome, and the stock moved +6.2% in the window around the event. It had already run +24.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.